(Press-News.org) AURORA, Colo. (June 22, 2023) – An article published today in the journal Lancet Neurology evaluates the risk of recurrence of active disease in older patients with multiple sclerosis after discontinuing disease-modifying therapies.
Multiple sclerosis (MS) is a chronic illness, often presenting in young adulthood. Most commonly, at onset, individuals have acute attacks, or relapses, of intermittent new neurological symptoms such as vision changes, numbness, and weakness that may come and go, seemingly randomly, and then remit completely or incompletely. These are associated with Magnetic Resonance Imaging (MRI) changes in the brain or spine. Over time, as people age, new attacks and MRI changes become less common, and either patients stabilize, or they may go into a phase of slow progressive neurological disability with minimal MRI changes.
There is no cure for MS, but there are now over 20 disease-modifying therapies (DMTs) that may substantially diminish the risks of new attacks and MRI changes. Most of the DMTs have been approved after studying only patients 55 and under, and these medications appear to have greatest impacts on younger patients with recent relapses, and modest effects on slowing progressive disability, especially in older patients. Thus, benefits in older patients remain unclear, while risks related to the DMTs may increase with age. Whether it is reasonable to stop using the DMTs as people age remains an important, unanswered question.
The article reports the results of a clinical trial known as DISCOMS, the first randomized, controlled, observer-blinded trial of discontinuation of MS DMTs. Between May 2017 and February 2020, researchers recruited 259 participants over 55 who had not had an acute MS relapse for at least five years and no new MRI lesion for at least three years from 19 MS centers in the United States. Using any new relapse or MRI scan change over two years as the main outcome, the study asked whether it was non-inferior to discontinue compared to staying on DMT. Only 22/259 (6/128 in the continue group and 16/131 in the discontinue group) total individuals had a new event (relapse or MRI scan change). By this measure, the researchers were unable to show non-inferiority, i.e. it could be inferior to stop DMT, noting that 15/22 of the new events were 1-2 new MRI lesions unaccompanied by any relapse or change in disability, and only four (one continue, three discontinue) participants had an acute relapse. There also was no increase in disability, symptom scores, cognitive tests, or adverse events in those discontinuing DMT.
John R. Corboy, MD, professor of neurology at the University of Colorado School of Medicine, is the lead investigator and primary author of the article. “Our study addresses important concerns about the risks and benefits of disease-modifying therapies as people age. The primary objective of our study was to identify whether discontinuation is safe to consider for older patients with multiple sclerosis and no recent relapse or new MRI activity, and our goal was to provide an estimate of disease recurrence in this context” Corboy says. He and his colleagues concluded that, while they were unable to show non-inferiority by this primary outcome, many patients 55 and older who have not had a relapse for five or more years might feel that the low risk of new clinical activity makes a personal discontinuation trial a reasonable option for them.
“This study will aid decision-making when health care providers and people with multiple sclerosis discuss potential disease-modifying therapy discontinuation as patients age” Corboy says. The study was funded by the Patient-Centered Outcomes Research Institute and the National Multiple Sclerosis Society.
END
CU professor leads study on discontinuing therapy for MS patients over 55
2023-06-23
ELSE PRESS RELEASES FROM THIS DATE:
Mystery of how leaf-cutting ants gauge leaf portion size revealed
2023-06-23
They might not be able to leap tall buildings with a single bound, but leaf-cutting ants are insect superheroes, capable of carrying leaf pieces up to six times their body mass to cultivate fungus in their borrows. But how do the charismatic creatures determine the size of the fragments they carve with their mandibles? Do they use their bodies as a simple ruler, or do they use information about the position of their bodies to adjust how far they cut, adapting to the thickness of a leaf while dismembering it? Knowing that the insects alter the trajectory of a cut when sculpting ®Parafilm of different thicknesses, Flavio ...
Ramón Barthelemy wins 2023 LGBTQ+ Educator of the Year
2023-06-22
Out to Innovate is proud to announce the winners of its 2023 recognition awards for lesbian, gay, bisexual, transgender, and queer (LGBTQ+) professionals in science, technology, engineering, and math (STEM). Out to Innovate has recognized exemplary individuals with LGBTQ+ Educator, Engineer, and Scientist of the Year for over 15 years.
2023 LGBTQ+ Educator of the Year: Ramón S. Barthelemy, Ph.D
The LGBTQ+ Educator of the Year award recognizes an educator who has significantly impacted STEM students through teaching, ...
Switch to MR angiography for PE mitigated impact of recent contrast shortage
2023-06-22
Leesburg, VA, June 22, 2023—According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), preferential use of pulmonary MR angiography (MRA) for diagnosing pulmonary embolus (PE) in the general population helped conserve iodinated contrast media during the 2022 shortage.
“This single-center experience demonstrates use of pulmonary MRA as a practical substitute for pulmonary CTA in emergency settings,” concluded lead investigator Jitka Starekova, MD, from the radiology ...
UW–Madison researchers reveal how the influenza A more effectively infect its hosts
2023-06-22
Influenza A is one of two influenza viruses that fuel costly annual flu seasons and is a near constant threat to humans and many other animals. It's also responsible for occasional pandemics that, like the one in 1918, leave millions dead and wreak havoc on health systems and wider society.
Influenza A was first identified as a health threat nearly a century ago, but only in the last decade have scientists identified one of the virus’s key proteins for infiltrating host cells and short-circuiting their defenses. Now, a team of researchers at the University of Wisconsin–Madison have taken a major step toward understanding how that protein works, ...
Powerful board allies are a CEO's best weapon
2023-06-22
If we’ve learned anything from HBO’s smash hit Succession over the last four years, it’s that, as the authors of a new Strategic Management Journal article state, “Even the most powerful individuals do not work alone.” Given that, whether (SPOILER ALERT!) Tom succeeds in his new role depends less on his business acumen than on who the new CEO has as his allies.
In the upcoming article “Can powerful allies protect the CEO against performance declines? The role of the CEO’s subgroup power in CEO dismissal,” authors Jihae You, Taekjin Shin, and Yunhyung Chung, explore ...
Working toward Black reproductive justice from the Library of Congress
2023-06-22
Historian Tamika Nunley can see the U.S. Supreme Court through the window of her office in the Library of Congress in Washington, D.C., where she is serving as the library’s Cary and Ann Maguire Chair in Ethics and American History this summer. It’s a great vantage point, she said, not only for looking out at landmarks of American government, but also for reflecting on the ways laws and judgements have negatively influenced Black maternal health throughout American history.
“I think the Library of Congress is one of the most democratic institutions we have, one of the best examples of what is possible in our democracy,” said Nunley, ...
Rensselaer researcher uses pressure to understand RNA dynamics
2023-06-22
Just as space holds infinite mysteries, when we zoom in at the level of biomolecules (one trillion times smaller than a meter), there is still so much to learn.
Rensselaer Polytechnic Institute’s Catherine Royer, Constellation Chair Professor of Bioinformatics and Biocomputation at the Shirley Ann Jackson, Ph.D. Center for Biotechnology and Interdisciplinary Studies (CBIS) and professor of biological sciences, is dedicated to understanding the conformational landscapes of biomolecules and how they modulate cell function. When biomolecules ...
New “atlas” maps bacteria and metabolites associated with elevated risk of cardiovascular disease
2023-06-22
CLEVELAND - A Cleveland Clinic research team recently published an “atlas” of metabolites associated with cardiovascular disease in the European Heart Journal. The novel findings provide key details about the routes and potential branching paths taken by bacteria and metabolic by-products, metabolites.
The study mapped out the multiple by-products of bacteria processing amino acids associated with cardiovascular disease and then compared that to patient data to assess disease risk in two large cohorts – one in the US and another in Europe.
Bacteria in and on our bodies produce metabolites through processing certain molecules, referred to as precursors. ...
Brigham researchers identify factors associated with lower breastfeeding duration for mothers with higher BMIs
2023-06-22
A multi-nation cohort analysis found that inflammation and cesarean section delivery in mothers with higher body mass index are connected to shorter duration of breastfeeding, providing potential targets for intervention.
Breastfeeding has significant benefits for both maternal and child health. Research has indicated that women with higher body mass index (BMI) have shorter durations of breastfeeding, but few underlying mechanisms have been identified. To address this gap, a new study led by investigators from Brigham and Women’s ...
Muhammad Rabnawaz to be inducted into National Academy of Inventors
2023-06-22
For creating technologies that have the potential to change the world and providing opportunities for future inventors, Muhammad Rabnawaz, an associate professor and Faculty Laureate in the College of Agriculture and Natural Resources at Michigan State University, will be inducted into the National Academy of Inventors as a senior member on June 26.
The NAI senior member program was established to highlight academic inventors who have demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions that hold the promise of making a tangible impact on the public’s quality of life, economic development and the welfare of society. Election ...